Neuropeptides 2003

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Alcalay R. N., Giladi E., Pick C. G., and Gozes I. Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci. Lett., in press.
Ashur-Fabian O., Segal-Ruder Y., Skutelsky E., Brenneman, D. E., Steingart R. A., Giladi E., and Gozes I. (2003) The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide. Peptides 24, 1413–1423.
Article PubMed CAS Google Scholar
Gozes I., and Brenneman D. E. (2000) A new concept in neuroprotection. J. Molec. Neurosci. 14, 61–68.
Article PubMed CAS Google Scholar
Gozes I., and Brenneman D. E. (2003) Summer neuropeptide conference. The 3rd joint meeting of the summer neuropeptide conference (13th annual meeting) and the European Neuropeptide Club (13th annual meeting) Montauk, NY, June 8–12, 2003. Neuropeptides 37, 157–158.
Article PubMed CAS Google Scholar

Department of Clinical Biochemistry, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, Sackler Faculty of Medicine, Tel Aviv University, 69978, Tel Aviv, Israel
Illana Gozes (Editor-in-Chief)
Allon Therapeutics, Inc., 92307, La Jolla, CA
Illana Gozes (Editor-in-Chief)

Authors

Illana Gozes
View author publications
You can also search for this author in PubMed Google Scholar

Gozes, I. Neuropeptides 2003. J Mol Neurosci 22, 1–2 (2004). https://doi.org/10.1385/JMN:22:1-2:1

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.